Skip to content
10-K

Annual Report

Praxis Precision Medicines, Inc. PRAX

0001689548-26-000029

← back to feed
Filed
Feb 19, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 16, 2026 27.85M sh
Shares Diluted FY 2025 · Dec 31, 2025 22.5M sh
Shares Diluted FY 2025 · Dec 31, 2024 17.91M sh
Shares Diluted FY 2025 · Dec 31, 2023 6.59M sh
Capex FY 2025 · Dec 31, 2025 $56K
Capex FY 2025 · Dec 31, 2024 $0
Capex FY 2025 · Dec 31, 2023 $50K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$249.07M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$131.76M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$111.14M
Cash And Equivalents FY 2025 · Dec 31, 2025 $357.33M
Cash And Equivalents FY 2025 · Dec 31, 2024 $215.37M
Cash And Equivalents FY 2025 · Dec 31, 2023 $81.3M
Stockholders Equity FY 2025 · Dec 31, 2025 $878.14M
Stockholders Equity FY 2025 · Dec 31, 2024 $445.45M
Stockholders Equity FY 2025 · Dec 31, 2023 $69.67M
Stockholders Equity FY 2025 · Dec 31, 2022 $76.11M
Current Liabilities FY 2025 · Dec 31, 2025 $59.77M
Current Liabilities FY 2025 · Dec 31, 2024 $37.55M
Total Liabilities FY 2025 · Dec 31, 2025 $59.77M
Total Liabilities FY 2025 · Dec 31, 2024 $37.66M
Current Assets FY 2025 · Dec 31, 2025 $610.91M
Current Assets FY 2025 · Dec 31, 2024 $404.37M
Total Assets FY 2025 · Dec 31, 2025 $937.91M
Total Assets FY 2025 · Dec 31, 2024 $483.11M
Eps Diluted FY 2025 · Dec 31, 2025 −$13.48
Eps Diluted FY 2025 · Dec 31, 2024 −$10.21
Eps Diluted FY 2025 · Dec 31, 2023 −$18.69
Eps Basic FY 2025 · Dec 31, 2025 −$13.48
Eps Basic FY 2025 · Dec 31, 2024 −$10.21
Eps Basic FY 2025 · Dec 31, 2023 −$18.69
Sga Expense FY 2025 · Dec 31, 2025 $59.08M
Sga Expense FY 2025 · Dec 31, 2024 $56.31M
Sga Expense FY 2025 · Dec 31, 2023 $42.05M
Rd Expense FY 2025 · Dec 31, 2025 $267.12M
Rd Expense FY 2025 · Dec 31, 2024 $152.41M
Rd Expense FY 2025 · Dec 31, 2023 $86.77M
Net Income FY 2025 · Dec 31, 2025 −$303.27M
Net Income FY 2025 · Dec 31, 2024 −$182.82M
Net Income FY 2025 · Dec 31, 2023 −$123.28M
Operating Income FY 2025 · Dec 31, 2025 −$326.2M
Operating Income FY 2025 · Dec 31, 2024 −$200.17M
Operating Income FY 2025 · Dec 31, 2023 −$126.37M
Revenue FY 2025 · Dec 31, 2025 $0
Revenue FY 2025 · Dec 31, 2024 $8.55M
Revenue FY 2025 · Dec 31, 2023 $2.45M